Barentsz, J. O., Richenberg, J., Clements, R., Choyke, P., Verma, S., Villeirs, G., Rouviere, O., Logager, V. & Fütterer, J. J. (2012). ESUR prostate MR guidelines 2012. Eur Radiol, 22(4), 746–757. https://doi.org/10.1007/s00330-011-2377-y

Article  PubMed  PubMed Central  Google Scholar 

Bratan, F., Niaf, E., Melodelima, C., Chesnais, A. L., Souchon, R., Mège-Lechevallier, F., Colombel, M. & Rouvière, O. (2013). Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol, 23(7), 2019–2029. https://doi.org/10.1007/s00330-013-2795-0

Article  PubMed  Google Scholar 

Drost, F. H., Osses, D. F., Nieboer, D., Steyerberg, E. W., Bangma, C. H., Roobol, M. J. & Schoots, I. G. (2019). Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev, 4(4), Cd012663. https://doi.org/10.1002/14651858.CD012663.pub2

Article  PubMed  Google Scholar 

Smeenge, M., Barentsz, J., Cosgrove, D., de la Rosette, J., de Reijke, T., Eggener, S., Frauscher, F., Kovacs, G., Matin, S. F., Mischi, M., Pinto, P., Rastinehad, A., Rouviere, O., Salomon, G., Polascik, T., Walz, J., Wijkstra, H. & Marberger, M. (2012). Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU Int, 110(7), 942–948. https://doi.org/10.1111/j.1464-410X.2012.11072.x

Article  PubMed  Google Scholar 

Meng, X., Rosenkrantz, A. B., Mendhiratta, N., Fenstermaker, M., Huang, R., Wysock, J. S., Bjurlin, M. A., Marshall, S., Deng, F. M., Zhou, M., Melamed, J., Huang, W. C., Lepor, H. & Taneja, S. S. (2016). Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Eur Urol, 69(3), 512–517. https://doi.org/10.1016/j.eururo.2015.06.005

Article  PubMed  Google Scholar 

Cornford, P., van den Bergh, R. C. N., Briers, E., Van den Broeck, T., Brunckhorst, O., Darraugh, J., Eberli, D., De Meerleer, G., De Santis, M., Farolfi, A., Gandaglia, G., Gillessen, S., Grivas, N., Henry, A. M., Lardas, M., van Leenders, G., Liew, M., Linares Espinos, E., Oldenburg, J., van Oort, I. M., Oprea-Lager, D. E., Ploussard, G., Roberts, M. J., Rouvière, O., Schoots, I. G., Schouten, N., Smith, E. J., Stranne, J., Wiegel, T., Willemse, P. M. & Tilki, D. (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol, 86(2), 148–163. https://doi.org/10.1016/j.eururo.2024.03.027

Article  PubMed  Google Scholar 

Wegelin, O., Exterkate, L., van der Leest, M., Kummer, J. A., Vreuls, W., de Bruin, P. C., Bosch, J., Barentsz, J. O., Somford, D. M. & van Melick, H. H. E. (2019). The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Eur Urol, 75(4), 582–590. https://doi.org/10.1016/j.eururo.2018.11.040

Article  PubMed  Google Scholar 

Rifkin, M. D., Zerhouni, E. A., Gatsonis, C. A., Quint, L. E., Paushter, D. M., Epstein, J. I., Hamper, U., Walsh, P. C. & McNeil, B. J. (1990). Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. N Engl J Med, 323(10), 621–626. https://doi.org/10.1056/nejm199009063231001

Article  CAS  PubMed  Google Scholar 

Kasabwala, K., Patel, N., Cricco-Lizza, E., Shimpi, A. A., Weng, S., Buchmann, R. M., Motanagh, S., Wu, Y., Banerjee, S., Khani, F., Margolis, D. J., Robinson, B. D. & Hu, J. C. (2019). The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy. Eur Urol Oncol, 2(2), 135–140. https://doi.org/10.1016/j.euo.2018.07.005

Article  PubMed  Google Scholar 

Windisch, O., Valerio, M., Yee, C. H., Gontero, P., Bakir, B., Kastner, C., Ahmed, H. U., De Nunzio, C. & de la Rosette, J. (2024). Biopsy strategies in the era of mpMRI: a comprehensive review. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-024-00884-2

Article  PubMed  PubMed Central  Google Scholar 

Wei, J. T., Barocas, D., Carlsson, S., Coakley, F., Eggener, S., Etzioni, R., Fine, S. W., Han, M., Kim, S. K., Kirkby, E., Konety, B. R., Miner, M., Moses, K., Nissenberg, M. G., Pinto, P. A., Salami, S. S., Souter, L., Thompson, I. M. & Lin, D. W. (2023). Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. J Urol, 210(1), 46–53. https://doi.org/10.1097/ju.0000000000003491

Article  PubMed  PubMed Central  Google Scholar 

Nam, J. K., Song, W. H., Lee, S. S., Lee, H. J., Kim, T. U. & Park, S. W. (2023). Impact of Ultrasonographic Findings on Cancer Detection Rate during Magnetic Resonance Image/Ultrasonography Fusion-Targeted Prostate Biopsy. World J Mens Health, 41(3), 743–749. https://doi.org/10.5534/wjmh.220268

Article  PubMed  PubMed Central  Google Scholar 

Press, B., Rosenkrantz, A. B., Huang, R. & Taneja, S. S. (2019). The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI-ultrasound fusion-targeted biopsy. BJU Int, 123(3), 439–446. https://doi.org/10.1111/bju.14615

Article  PubMed  Google Scholar 

Yoo, J. W. & Lee, K. S. (2022). Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study. Prostate Int, 10(1), 28–33. https://doi.org/10.1016/j.prnil.2021.11.002

Article  PubMed  Google Scholar 

Shakir, N. A., Siddiqui, M. M., George, A. K., Kongnyuy, M., Ho, R., Fascelli, M., Merino, M. J., Turkbey, B., Choyke, P. L., Wood, B. J. & Pinto, P. A. (2017). Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy? Urology, 105, 113–117. https://doi.org/10.1016/j.urology.2016.11.012

Article  PubMed  Google Scholar 

Choi, M. H., Lee, Y. J., Jung, S. E., Lee, J. Y. & Choi, Y. J. (2019). Prostate cancer detection rate according to lesion visibility using ultrasound and MRI. Clin Radiol, 74(6), 474–479. https://doi.org/10.1016/j.crad.2019.02.002

Article  CAS  PubMed  Google Scholar 

Falkenbach, F., Ahmad-Sterkau, F., Kachanov, M., Beyersdorff, D., Koehler, D., Ambrosini, F., Ortner, G., Maurer, T., Graefen, M. & Budäus, L. (2024). Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound. Prostate. https://doi.org/10.1002/pros.24785

Article  PubMed  PubMed Central  Google Scholar 

Pepe, P., Pepe, L., Panella, P. & Pennisi, M. (2020). Can multiparametric ultrasound improve cognitive MRI/TRUS fusion prostate biopsy. Arch Ital Urol Androl, 92(2). https://doi.org/10.4081/aiua.2020.2.89

Qin, F., Liu, Z., Ma, J., Wu, J., Shen, Q., Liu, Y. & Li, X. (2024). Visibility of mpMRI region of interest on ultrasound during cognitive fusion targeted biopsy predicts prostate cancer detection: a prospective single-center study. Abdom Radiol (NY). https://doi.org/10.1007/s00261-024-04750-6

Article  PubMed  Google Scholar 

Pepe, P., Pepe, L., Tamburo, M., Marletta, G., Savoca, F., Pennisi, M. & Fraggetta, F. (2023). (68)Ga-PSMA PET/CT and Prostate Cancer Diagnosis: Which SUVmax Value? In Vivo, 37(3), 1318–1322. https://doi.org/10.21873/invivo.13211

Article  CAS  Google Scholar 

Emmett, L., Papa, N., Hope, T. A., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Counter, W., John, N., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Agrawal, S., Ho, B., Nguyen, A., Liu, V., Lee, J., Woo, H., Hsiao, E., Sutherland, T., Perry, E., Stricker, P., Hofman, M. S., Kasivisvanathan, V., Roberts, M. & Murphy, D. (2024). Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer. J Urol, 212(2), 299–309. https://doi.org/10.1097/ju.0000000000004010

Garcia-Reyes, K., Nguyen, H. G., Zagoria, R. J., Shinohara, K., Carroll, P. R., Behr, S. C. & Westphalen, A. C. (2018). Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy. J Urol, 199(3), 699–705. https://doi.org/10.1016/j.juro.2017.09.075

Article  PubMed  Google Scholar 

Turkbey, B., Rosenkrantz, A. B., Haider, M. A., Padhani, A. R., Villeirs, G., Macura, K. J., Tempany, C. M., Choyke, P. L., Cornud, F., Margolis, D. J., Thoeny, H. C., Verma, S., Barentsz, J. & Weinreb, J. C. (2019). Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol, 76(3), 340–351. https://doi.org/10.1016/j.eururo.2019.02.033

Pepe, P. & Pennisi, M. (2022). Morbidity following transperineal prostate biopsy: Our experience in 8.500 men. Arch Ital Urol Androl, 94(2), 155–159. https://doi.org/10.4081/aiua.2022.2.155

Article  PubMed  Google Scholar